Viewing Study NCT00039234


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2025-12-31 @ 8:45 PM
Study NCT ID: NCT00039234
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2002-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
Sponsor: Maxim Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module